Prostate Cancer - Results from #27600

Insulin-like growth factor pathway: A link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? - Abstract June 29, 2011

Career opportunity: Chief Scientific Officer, Prostate Cancer Canada (PCC) June 29, 2011

Editor's Commentary - The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivation June 29, 2011

The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy - Abstract June 28, 2011

Evolution of modern imaging and development of targeted prostatic biopsies for the diagnosis of prostate cancer - Abstract June 28, 2011

Cancer multitarget pharmacology in prostate tumors: Tyrosine kinase inhibitors and beyond - Abstract June 28, 2011

Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence - Abstract June 28, 2011

Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS) - Abstract June 28, 2011

Treatment effects in the prostate including those associated with traditional and emerging therapies - Abstract June 28, 2011

Prostate volume has prognostic value only in pathologic T2 radical prostatectomy specimens - Abstract June 28, 2011

Association of short tandem repeat polymorphism in the promoter of prostate cancer antigen 3 gene with the risk of prostate cancer - Abstract June 28, 2011

Watchful waiting and active surveillance approach in patients with low risk localized prostatic cancer: An experience of out-patients clinic with 12-year follow-up - Abstract June 28, 2011

Patient centeredness and decision-making in localised prostate cancer : Possible fields of health services research in urology - Abstract June 28, 2011

Prostate-specific antigen velocity before and after elimination of factors that can confound the prostate-specific antigen level - Abstract June 27, 2011

Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer - Abstract June 27, 2011

Impact of hypoxia on the metastatic potential of human prostate cancer cells - Abstract June 27, 2011

Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: A systematic review - Abstract June 27, 2011

Mindfulness groups for men with advanced prostate cancer: A pilot study to assess feasibility and effectiveness and the role of peer support - Abstract June 27, 2011

The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: A population-based study - Abstract June 27, 2011

Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease - Abstract June 27, 2011

Page 1381 of 1436